US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Editas Medicine

1.61

+0.05003.21%

Pre-market: 1.690.0800+4.97%05:39 EDT

Volume:1.13M

Turnover:1.77M

Market Cap:133.59M

PE:-0.56

High:1.62

Open:1.55

Low:1.49

Close:1.56

Loading ...

Overview Company News Filings

Editas Medicine Updates RUBY Trial with Promising Results

Editas Medicine Shares Jump as Potential Gene Therapy for Sickle Cell Disease Found to Be 'Well-Tolerated'

MT Newswires Live

Editas Medicine reports updated clinical data from RUBY trial of Reni-cel

Editas Medicine Reports Updated Clinical Data From the Ruby Trial of Reni-Cel in Patients With Severe Sickle Cell Disease at the American Society of Hematology (Ash) Annual Meeting

THOMSON REUTERS

Editas Medicine Reports Updated Clinical Data from the RUBY Trial of Reni-cel in Patients with Severe Sickle Cell Disease at the American Society of Hematology (ASH) Annual Meeting

Why Is Editas (EDIT) Down 36.5% Since Last Earnings Report?

Editas cut to underperform by BofA, price objective slashed to $1

Bank of America Securities downgrades Editas Medicine (EDIT) to a Sell

BofA Securities Downgrades Editas Medicine to Underperform

MT Newswires Live

Editas Medicine downgraded to Underperform from Buy at BofA

CRISPR Therapeutics Stock Falls 7% in Two Weeks: Time to Hold or Sell?

Editas Medicine upgraded to Outperform from In Line at Evercore ISI

Editas Medicine to Participate in Upcoming Investor Conferences

Growth Investors: Industry Analysts Just Upgraded Their Editas Medicine, Inc. (NASDAQ:EDIT) Revenue Forecasts By 19%

Simply Wall St.

Cautious Optimism for Editas Medicine Amid Strategic Milestones and Competitive Pressures

Buy Rating for Editas Medicine Driven by Strategic Focus on In Vivo CRISPR Gene Editing and Intellectual Property Catalysts

Editas Medicine’s Strong Financial Position and Promising Clinical Progress Drive Buy Rating

Editas Medicine: Strategic Advancements and Promising Clinical Developments Justify Buy Rating

Editas Medicine Downgraded by Raymond James Amid Strategic Shift and Program Uncertainty

Editas Q3 Loss Narrower Than Expected, Revenues Decrease Y/Y

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EDIT/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EDIT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EDIT\",,,,,undefined,":{"symbol":"EDIT","market":"US","secType":"STK","nameCN":"Editas Medicine","latestPrice":1.61,"timestamp":1745524800000,"preClose":1.56,"halted":0,"volume":1132492,"hourTrading":{"tag":"盘前","latestPrice":1.69,"preClose":1.61,"latestTime":"05:39 EDT","volume":50,"amount":84.5,"timestamp":1745573945102},"delay":0,"floatShares":82676988,"shares":82976284,"eps":-2.879501,"marketStatus":"Pre-Mkt","change":0.05,"latestTime":"04-25 06:39:34 EDT","open":1.55,"high":1.62,"low":1.4916,"amount":1774467.9665384002,"amplitude":0.082308,"askPrice":1.73,"askSize":15,"bidPrice":1.51,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-2.879501,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745587800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.61,"preHourTrading":{"tag":"盘前","latestPrice":1.69,"preClose":1.61,"latestTime":"05:39 EDT","volume":50,"amount":84.5,"timestamp":1745573945102},"postHourTrading":{"tag":"盘后","latestPrice":1.63,"preClose":1.61,"latestTime":"19:59 EDT","volume":42692,"amount":69264.5001,"timestamp":1745539191110},"volumeRatio":0.5984922429704995,"impliedVol":1.8793,"impliedVolPercentile":0.9679},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EDIT\",,,,,undefined,":{"symbol":"EDIT","floatShares":82676988,"roa":"-35.52%","roe":"-98.10%","lyrEps":-2.879501,"volumeRatio":0.5984922429704995,"shares":82976284,"dividePrice":0,"high":1.62,"amplitude":0.082308,"preClose":1.56,"low":1.4916,"week52Low":0.9101,"pbRate":"0.99","psRate":"4.13","week52High":6.69,"institutionHeld":0,"latestPrice":1.61,"committee":0.860465,"eps":-2.879501,"divideRate":0,"volume":1132492,"delay":0,"ttmEps":-2.879501,"open":1.55,"prevYearClose":1.27,"prevWeekClose":1.28,"prevMonthClose":1.16,"prevQuarterClose":1.16,"fiveDayClose":1.27,"twentyDayClose":1.27,"sixtyDayClose":1.42},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EDIT\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2490629099","title":"Editas Medicine Updates RUBY Trial with Promising Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2490629099","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490629099?lang=en_us&edition=fundamental","pubTime":"2024-12-10 19:29","pubTimestamp":1733830180,"startTime":"0","endTime":"0","summary":"An announcement from Editas Medicine ( ($EDIT) ) is now available. Editas Medicine has updated the clinical data from its RUBY trial, showcasing pr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/editas-medicine-updates-ruby-trial-with-promising-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/editas-medicine-updates-ruby-trial-with-promising-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","EDIT","BK4139","BK4556","RUBY"],"gpt_icon":0},{"id":"2490703364","title":"Editas Medicine Shares Jump as Potential Gene Therapy for Sickle Cell Disease Found to Be 'Well-Tolerated'","url":"https://stock-news.laohu8.com/highlight/detail?id=2490703364","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490703364?lang=en_us&edition=fundamental","pubTime":"2024-12-10 01:25","pubTimestamp":1733765114,"startTime":"0","endTime":"0","summary":"Editas Medicine  shares were up almost 7% in recent trading Monday after the company said that its renizgamglogene autogedtemcel, or reni-cel, therapy continued to be well-tolerated in sickle cell disease patients.Updated data from the company's clinical trial showed that all 28 subjects with severe sickle cell disease showed a safety profile consistent with myeloablative busulfan conditioning and autologous hematopoietic stem cell transplant, Editas said.The company also said that 27 of the patients experienced no vaso-occlusive events, that cause pain and other complications, while some patients showed improvements in markers such as hemoglobin levels and fetal hemoglobin.Editas said it would present the updated clinical data at the American Society of Hematology annual meeting on Monday.Price: 2.29, Change: +0.15, Percent Change: +6.78","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4556","EDIT","BK4139"],"gpt_icon":0},{"id":"2490708156","title":"Editas Medicine reports updated clinical data from RUBY trial of Reni-cel","url":"https://stock-news.laohu8.com/highlight/detail?id=2490708156","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490708156?lang=en_us&edition=fundamental","pubTime":"2024-12-10 01:10","pubTimestamp":1733764214,"startTime":"0","endTime":"0","summary":"Editas Medicine (EDIT) will present updated safety and efficacy data in 28 patients living with severe sickle cell disease treated with renizgamglo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/editas-medicine-reports-updated-clinical-data-from-ruby-trial-of-reni-cel?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/editas-medicine-reports-updated-clinical-data-from-ruby-trial-of-reni-cel?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RUBY","BK4139","EDIT","BK4556","BK4535"],"gpt_icon":0},{"id":"2490770796","title":"Editas Medicine Reports Updated Clinical Data From the Ruby Trial of Reni-Cel in Patients With Severe Sickle Cell Disease at the American Society of Hematology (Ash) Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2490770796","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490770796?lang=en_us&edition=fundamental","pubTime":"2024-12-10 01:00","pubTimestamp":1733763601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nTUA27D37B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4556","EDIT","BK4139"],"gpt_icon":0},{"id":"2490708355","title":"Editas Medicine Reports Updated Clinical Data from the RUBY Trial of Reni-cel in Patients with Severe Sickle Cell Disease at the American Society of Hematology (ASH) Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2490708355","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490708355?lang=en_us&edition=fundamental","pubTime":"2024-12-10 01:00","pubTimestamp":1733763600,"startTime":"0","endTime":"0","summary":"Poster presentation at ASH on Monday, December 9 at 6:00 p.m. PT / 9:00 p.m. ET CAMBRIDGE, Mass., Dec.  09, 2024  (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading gene editing compa","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/09/2993977/0/en/Editas-Medicine-Reports-Updated-Clinical-Data-from-the-RUBY-Trial-of-Reni-cel-in-Patients-with-Severe-Sickle-Cell-Disease-at-the-American-Society-of-Hematology-ASH-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AFG","BK4585","CRSP","LU1861559042.SGD","BK4117","EDIT","SCD","BK4109","BK4139","BK4556","LU2463526074.USD","LU1861558580.USD","RUBY","ASH","BK4535","BK4588","BK4107"],"gpt_icon":0},{"id":"2489148917","title":"Why Is Editas (EDIT) Down 36.5% Since Last Earnings Report?","url":"https://stock-news.laohu8.com/highlight/detail?id=2489148917","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489148917?lang=en_us&edition=fundamental","pubTime":"2024-12-05 00:30","pubTimestamp":1733329849,"startTime":"0","endTime":"0","summary":"It has been about a month since the last earnings report for Editas Medicine . Shares have lost about 36.5% in that time frame, underperforming the S&P 500.Will the recent negative trend continue leading up to its next earnings release, or is Editas due for a breakout?Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.Editas Q3 Loss Narrower Than Expected, Revenues Decrease Y/Y. Editasincurred a loss of 75 cents per share in the third quarter of 2024, narrower than the Zacks Consensus Estimate of a loss of 76 cents. The company had reported a loss of 55 cents per share in the year-ago quarter.Collaboration and other research and development (R&D) revenues, which comprise the company’s top line, were $0.1 million in the reported quarter, down from $5.3 million reported in the year-ago quarter. The reported figure missed the Zacks Consensus Estimate of ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Fj4TPQveJWuth16WIsEVAw--~B/aD01OTQ7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/46ebfcbff417ac1bbde85ad33fa0d4be","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Fj4TPQveJWuth16WIsEVAw--~B/aD01OTQ7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/46ebfcbff417ac1bbde85ad33fa0d4be"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-editas-edit-down-36-163049860.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EDIT","EXEL"],"gpt_icon":0},{"id":"2486034035","title":"Editas cut to underperform by BofA, price objective slashed to $1","url":"https://stock-news.laohu8.com/highlight/detail?id=2486034035","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486034035?lang=en_us&edition=fundamental","pubTime":"2024-11-26 00:31","pubTimestamp":1732552298,"startTime":"0","endTime":"0","summary":"Bet_Noire BofA has downgraded Editas (NASDAQ:EDIT) to underperform from buy, citing the company’s plans to outsource its reni-cel program.  “Deprioritizing reni-cel does make sense from a cash burn perspective but removes a significant portion of our valuation with partner interest remaining","market":"us","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1390517125/image_1390517125.jpg?io=getty-c-w750","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1390517125/image_1390517125.jpg?io=getty-c-w750"],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4330713-editas-cut-to-underperform-by-bofa-price-objective-slashed-to-1-dollar","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["EDIT"],"gpt_icon":0},{"id":"2486033661","title":"Bank of America Securities downgrades Editas Medicine (EDIT) to a Sell","url":"https://stock-news.laohu8.com/highlight/detail?id=2486033661","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486033661?lang=en_us&edition=fundamental","pubTime":"2024-11-25 22:55","pubTimestamp":1732546552,"startTime":"0","endTime":"0","summary":"Editas Medicine (EDIT – Research Report) received a Sell rating and price target from Bank of America Securities analyst Alec Stranahan on November...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-downgrades-editas-medicine-edit-to-a-sell?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-downgrades-editas-medicine-edit-to-a-sell?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BAC","EDIT"],"gpt_icon":0},{"id":"2486908689","title":"BofA Securities Downgrades Editas Medicine to Underperform","url":"https://stock-news.laohu8.com/highlight/detail?id=2486908689","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486908689?lang=en_us&edition=fundamental","pubTime":"2024-11-25 20:51","pubTimestamp":1732539068,"startTime":"0","endTime":"0","summary":"Editas Medicine (EDIT) has an average rating of overweight and mean price target of $8.15, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EDIT"],"gpt_icon":0},{"id":"2486608833","title":"Editas Medicine downgraded to Underperform from Buy at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2486608833","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486608833?lang=en_us&edition=fundamental","pubTime":"2024-11-25 19:50","pubTimestamp":1732535442,"startTime":"0","endTime":"0","summary":"BofA downgraded Editas Medicine (EDIT) to Underperform from Buy with a price target of $1, down from $13, after the company recently announced plan...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/editas-medicine-downgraded-to-underperform-from-buy-at-bofa?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/editas-medicine-downgraded-to-underperform-from-buy-at-bofa?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EDIT"],"gpt_icon":0},{"id":"2485914405","title":"CRISPR Therapeutics Stock Falls 7% in Two Weeks: Time to Hold or Sell?","url":"https://stock-news.laohu8.com/highlight/detail?id=2485914405","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485914405?lang=en_us&edition=fundamental","pubTime":"2024-11-20 22:21","pubTimestamp":1732112460,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics’ CRSP shares have lost 6.6% in the past two weeks compared with the industry’s 8.4% decline, as seen in the chart below. The stock has underperformed the sector and the S&P 500 index. Shares of the company are also currently trading below its 50-day and 200-day moving averages.Approval for First CRISPR-Based Therapy: A Boon for CRSP Stock. This approval was a breakthrough for medical science, as it was the first for a CRISPR-based gene-editing therapy. Both SCD and TDT indications have a significant unmet medical need. Casgevy has the potential to alleviate blood transfusion requirements for TDT patients and reduce painful and debilitating sickle crises for SCD patients. Per management, the therapy offers a new treatment option to nearly 35,000 patients living with severe SCD or TDT across the United States and Europe, with additional patients in Bahrain and Saudi Arabia.CRISPR Therapeutics is yet to record collaboration revenues from Vertex for Casgevy sales.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/B7EfA6ERTo_QO90H15uyXw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/B7EfA6ERTo_QO90H15uyXw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/crispr-therapeutics-stock-falls-7-142100045.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2417539215.USD","IE00B19Z9P08.USD","LU1093756168.USD","LU2236285917.USD","LU0058720904.USD","VRTX","LU0079474960.USD","IE00B4R5TH58.HKD","IE0002270589.USD","LU0417517546.SGD","BEAM","IE00B19Z3581.USD","LU0109394709.USD","LU0289739699.SGD","IE00B19Z3B42.SGD","BK4588","LU1430594728.SGD","EDIT","IE00B19Z9Z06.USD","IE00BJJMRZ35.SGD","LU0256863811.USD","LU0320765992.SGD","BK4585","BK4077","IE00B2B36J28.USD","SCD","IE00BFTCPJ56.SGD","BK4567","LU1861559042.SGD","LU2362541513.USD","LU2456880835.USD","LU0061475181.USD","BK4535","LU2462157665.USD","LU1585245621.USD","LENZ","LU0889565916.HKD","LU2237438978.USD","BK4139","BK4556","LU2362541273.HKD","BK4532","BK4533","SLE","LU1069344957.HKD","BK4505","LU1093756325.SGD","IE0009355771.USD","CRSP","LU1035775433.USD"],"gpt_icon":0},{"id":"2481518933","title":"Editas Medicine upgraded to Outperform from In Line at Evercore ISI","url":"https://stock-news.laohu8.com/highlight/detail?id=2481518933","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481518933?lang=en_us&edition=fundamental","pubTime":"2024-11-07 00:50","pubTimestamp":1730911809,"startTime":"0","endTime":"0","summary":"Evercore ISI upgraded Editas Medicine (EDIT) to Outperform from In Line with a $7 price target Published first on TheFly – the ultimate source for ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/editas-medicine-upgraded-to-outperform-from-in-line-at-evercore-isi?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/editas-medicine-upgraded-to-outperform-from-in-line-at-evercore-isi?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EDIT"],"gpt_icon":0},{"id":"2481027586","title":"Editas Medicine to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2481027586","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481027586?lang=en_us&edition=fundamental","pubTime":"2024-11-06 22:00","pubTimestamp":1730901600,"startTime":"0","endTime":"0","summary":"Cristi Barnett. (617) 401-0113. cristi.barnett@editasmed.com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/06/2975745/0/en/Editas-Medicine-to-Participate-in-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRSP","LU1861558580.USD","LU1861559042.SGD","BK4588","BK4556","EDIT","BK4585"],"gpt_icon":0},{"id":"2481080326","title":"Growth Investors: Industry Analysts Just Upgraded Their Editas Medicine, Inc. (NASDAQ:EDIT) Revenue Forecasts By 19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481080326","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481080326?lang=en_us&edition=fundamental","pubTime":"2024-11-06 20:02","pubTimestamp":1730894569,"startTime":"0","endTime":"0","summary":"Editas Medicine, Inc.  shareholders will have a reason to smile today, with the analysts making substantial upgrades to next year's statutory forecasts. The revenue forecast for next year has experienced a facelift, with the analysts now much more optimistic on its sales pipeline.After the upgrade, the consensus from Editas Medicine's 16 analysts is for revenues of US$21m in 2025, which would reflect a sizeable 65% decline in sales compared to the last year of performance. Losses are forecast to narrow 2.5% to US$2.49 per share. Yet before this consensus update, the analysts had been forecasting revenues of US$18m and losses of US$2.59 per share in 2025. We can see there's definitely been a change in sentiment in this update, with the analysts administering a sizeable upgrade to next year's revenue estimates, while at the same time reducing their loss estimates.Of course, seeing company management  invest large sums of money in a stock can be just as useful as knowing whether analysts ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b"],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/growth-investors-industry-analysts-just-120249068.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NDAQ",".IXIC","ISBC","EDIT"],"gpt_icon":0},{"id":"2481541625","title":"Cautious Optimism for Editas Medicine Amid Strategic Milestones and Competitive Pressures","url":"https://stock-news.laohu8.com/highlight/detail?id=2481541625","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481541625?lang=en_us&edition=fundamental","pubTime":"2024-11-06 16:18","pubTimestamp":1730881086,"startTime":"0","endTime":"0","summary":"Analyst Mani Foroohar from Leerink Partners reiterated a Hold rating on Editas Medicine (EDIT – Research Report) and keeping the price target at $8...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cautious-optimism-for-editas-medicine-amid-strategic-milestones-and-competitive-pressures?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cautious-optimism-for-editas-medicine-amid-strategic-milestones-and-competitive-pressures?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4556","EDIT"],"gpt_icon":0},{"id":"2481625631","title":"Buy Rating for Editas Medicine Driven by Strategic Focus on In Vivo CRISPR Gene Editing and Intellectual Property Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2481625631","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481625631?lang=en_us&edition=fundamental","pubTime":"2024-11-06 16:16","pubTimestamp":1730880971,"startTime":"0","endTime":"0","summary":"Jack Allen, an analyst from Robert W. Baird, maintained the Buy rating on Editas Medicine (EDIT – Research Report). The associated price target rem...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/buy-rating-for-editas-medicine-driven-by-strategic-focus-on-in-vivo-crispr-gene-editing-and-intellectual-property-catalysts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/buy-rating-for-editas-medicine-driven-by-strategic-focus-on-in-vivo-crispr-gene-editing-and-intellectual-property-catalysts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRSP","EDIT"],"gpt_icon":0},{"id":"2481549996","title":"Editas Medicine’s Strong Financial Position and Promising Clinical Progress Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2481549996","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481549996?lang=en_us&edition=fundamental","pubTime":"2024-11-06 05:35","pubTimestamp":1730842512,"startTime":"0","endTime":"0","summary":"Analyst Geulah Livshits of Chardan Capital reiterated a Buy rating on Editas Medicine (EDIT – Research Report), retaining the price target of $12.0...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/editas-medicines-strong-financial-position-and-promising-clinical-progress-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/editas-medicines-strong-financial-position-and-promising-clinical-progress-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS","EDIT"],"gpt_icon":0},{"id":"2481637280","title":"Editas Medicine: Strategic Advancements and Promising Clinical Developments Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2481637280","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481637280?lang=en_us&edition=fundamental","pubTime":"2024-11-06 03:15","pubTimestamp":1730834118,"startTime":"0","endTime":"0","summary":"JonesTrading analyst Soumit Roy has maintained their bullish stance on EDIT stock, giving a Buy rating today. Soumit Roy’s rating is based on Edita...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/editas-medicine-strategic-advancements-and-promising-clinical-developments-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/editas-medicine-strategic-advancements-and-promising-clinical-developments-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EDIT"],"gpt_icon":0},{"id":"2481347056","title":"Editas Medicine Downgraded by Raymond James Amid Strategic Shift and Program Uncertainty","url":"https://stock-news.laohu8.com/highlight/detail?id=2481347056","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481347056?lang=en_us&edition=fundamental","pubTime":"2024-11-06 02:59","pubTimestamp":1730833167,"startTime":"0","endTime":"0","summary":"Raymond James downgraded Editas Medicine  from outperform to market perform, citing extended development timelines and uncertainties surrounding its in vivo gene-editing program.GuruFocus has detected 6 Warning Signs with EDIT.With the next program update planned in the first quarter of 2025, the investment company highlighted Editas has now turned its attention to in vivo editing for treating sickle cell illness and beta thalassemia. Although this technique might provide a safety benefit by maybe removing the requirement for myeloablative conditioning, Raymond James voiced doubts regarding its effectiveness relative to the approved ex vivo technique.The company also underlined that Editas is trying to out-license its reni-cel treatment, a procedure it described as difficult given the low commercialization of rival treatments. Particularly, Vertex Pharmaceuticals  and CRISpen Therapeutics  have created a competing treatment called Casgevy with revised sales projections shortly.New resu","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/gl.H4nENbLXSRe03.Bos.g--~B/aD0zNjY7dz01NTA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/15af21c53224ce854302d72122cdb690","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/gl.H4nENbLXSRe03.Bos.g--~B/aD0zNjY7dz01NTA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/15af21c53224ce854302d72122cdb690"],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/editas-medicine-downgraded-raymond-james-185927728.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RJF","EDIT"],"gpt_icon":0},{"id":"2481488636","title":"Editas Q3 Loss Narrower Than Expected, Revenues Decrease Y/Y","url":"https://stock-news.laohu8.com/highlight/detail?id=2481488636","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481488636?lang=en_us&edition=fundamental","pubTime":"2024-11-06 00:01","pubTimestamp":1730822460,"startTime":"0","endTime":"0","summary":"Editas Medicine EDIT incurred a loss of 75 cents per share in the third quarter of 2024, narrower than the Zacks Consensus Estimate of a loss of 76 cents. The company had reported a loss of 55 cents per share in the year-ago quarter.Collaboration and other research and development (R&D) revenues, which comprise the company’s top line, were $0.1 million in the reported quarter, down from $5.3 million reported in the year-ago quarter. The reported figure missed the Zacks Consensus Estimate of $7 million. The year-over-year decline in revenues can be attributed to an upfront payment received in the year-ago quarter for a non-exclusive license grant toVor Bio.Stay up-to-date with all quarterly releases:See ZacksEarnings Calendar.General and administrative expenses were $18.1 million in the reported quarter, up 21% year over year, due to increased employee-related expenses because of ahigher headcount to support business operations for progressing thereni-cel program.EDIT has completed enro","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/TnZya4zmXcZQTiM85rn8xg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/955c0f2ed0992898cedf76a9efa5b1f2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/TnZya4zmXcZQTiM85rn8xg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/955c0f2ed0992898cedf76a9efa5b1f2"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/editas-q3-loss-narrower-expected-160100990.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVS","EDIT"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":5,"totalSize":133,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EDIT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-05","symbol":"EDIT","fiscalQuarterEnding":"2024/12","expectedEps":-0.39,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741150800000,"reportTimeType":"post","actualEps":-0.55},{"market":"US","date":"2024-11-04","symbol":"EDIT","fiscalQuarterEnding":"2024/09","expectedEps":-0.76,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730696400000,"reportTimeType":"pre","actualEps":-0.75},{"market":"US","date":"2024-08-07","symbol":"EDIT","fiscalQuarterEnding":"2024/06","expectedEps":-0.69,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"pre","actualEps":-0.82},{"market":"US","date":"2024-05-08","symbol":"EDIT","fiscalQuarterEnding":"2024/03","expectedEps":-0.63,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-0.76},{"market":"US","date":"2024-02-28","symbol":"EDIT","fiscalQuarterEnding":"2023/12","expectedEps":-0.52,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1709096400000,"reportTimeType":"pre","actualEps":-0.23}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EDIT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EDIT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1333,"buy":0.1333,"hold":0.6,"sell":0.1333,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.6,"analysts":15,"updateTime":1734408000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EDIT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EDIT","date":"2025-04-24","current":-0.545959,"percent":0.947068,"low":-61.372415,"twenty":-15.973957,"median":-4.496422,"eighty":-2.618581,"high":-0.343009,"avg":-9.425094,"sd":10.76815,"marketCap":129443003},"quantilePoints":[{"date":"2020-05-01","current":-9.029844,"twenty":-14.591609,"median":-11.456152,"eighty":-9.229122,"marketCap":1207705552},{"date":"2020-05-08","current":-9.456994,"twenty":-14.548507,"median":-11.453191,"eighty":-9.229122,"marketCap":1344983091},{"date":"2020-05-15","current":-10.057863,"twenty":-14.529073,"median":-11.42335,"eighty":-9.235553,"marketCap":1430439321},{"date":"2020-05-22","current":-11.519851,"twenty":-14.505936,"median":-11.420393,"eighty":-9.245399,"marketCap":1638364672},{"date":"2020-05-29","current":-10.360211,"twenty":-14.488689,"median":-11.396116,"eighty":-9.253638,"marketCap":1473439590},{"date":"2020-06-05","current":-10.203296,"twenty":-14.472302,"median":-11.389319,"eighty":-9.25614,"marketCap":1451122995},{"date":"2020-06-12","current":-10.329594,"twenty":-14.462347,"median":-11.37883,"eighty":-9.260592,"marketCap":1469085132},{"date":"2020-06-19","current":-12.308252,"twenty":-14.43874,"median":-11.382486,"eighty":-9.266017,"marketCap":1750491955},{"date":"2020-06-26","current":-12.51885,"twenty":-14.432211,"median":-11.39303,"eighty":-9.286702,"marketCap":1780443402},{"date":"2020-07-02","current":-13.215785,"twenty":-14.420263,"median":-11.409216,"eighty":-9.293748,"marketCap":1879562139},{"date":"2020-07-10","current":-14.230885,"twenty":-14.432476,"median":-11.42335,"eighty":-9.305007,"marketCap":2023930734},{"date":"2020-07-17","current":-13.951679,"twenty":-14.420263,"median":-11.448748,"eighty":-9.314422,"marketCap":1984221675},{"date":"2020-07-24","current":-12.934414,"twenty":-14.407802,"median":-11.455828,"eighty":-9.331056,"marketCap":1839545258},{"date":"2020-07-31","current":-12.709317,"twenty":-14.39591,"median":-11.463213,"eighty":-9.341419,"marketCap":1807531752},{"date":"2020-08-07","current":-16.237575,"twenty":-14.407802,"median":-11.484028,"eighty":-9.345359,"marketCap":2143473530},{"date":"2020-08-14","current":-16.335814,"twenty":-14.464081,"median":-11.500856,"eighty":-9.350788,"marketCap":2156441823},{"date":"2020-08-21","current":-16.87847,"twenty":-14.536847,"median":-11.519851,"eighty":-9.353148,"marketCap":2228076202},{"date":"2020-08-28","current":-16.354526,"twenty":-14.606636,"median":-11.52554,"eighty":-9.369617,"marketCap":2158911974},{"date":"2020-09-04","current":-14.254074,"twenty":-14.647892,"median":-11.530456,"eighty":-9.380788,"marketCap":1881637524},{"date":"2020-09-11","current":-14.029527,"twenty":-14.633809,"median":-11.548293,"eighty":-9.38426,"marketCap":1851995712},{"date":"2020-09-18","current":-15.858651,"twenty":-14.666176,"median":-11.559568,"eighty":-9.3951,"marketCap":2093452972},{"date":"2020-09-25","current":-13.758199,"twenty":-14.691656,"median":-11.569123,"eighty":-9.410378,"marketCap":1816178522},{"date":"2020-10-02","current":-12.663531,"twenty":-14.676019,"median":-11.581366,"eighty":-9.420828,"marketCap":1671674689},{"date":"2020-10-09","current":-15.479728,"twenty":-14.676019,"median":-11.591255,"eighty":-9.428685,"marketCap":2043432414},{"date":"2020-10-16","current":-15.746378,"twenty":-14.733358,"median":-11.604712,"eighty":-9.443612,"marketCap":2078632066},{"date":"2020-10-23","current":-15.325351,"twenty":-14.773079,"median":-11.617915,"eighty":-9.453743,"marketCap":2023053669},{"date":"2020-10-30","current":-14.473943,"twenty":-14.788655,"median":-11.625061,"eighty":-9.45926,"marketCap":1910661798},{"date":"2020-11-06","current":-20.658478,"twenty":-14.793622,"median":-11.648478,"eighty":-9.471799,"marketCap":1885024126},{"date":"2020-11-13","current":-19.804766,"twenty":-14.871784,"median":-11.650628,"eighty":-9.487845,"marketCap":1807125458},{"date":"2020-11-20","current":-19.255951,"twenty":-14.909041,"median":-11.667851,"eighty":-9.492925,"marketCap":1757047742},{"date":"2020-11-27","current":-21.234395,"twenty":-14.929289,"median":-11.693693,"eighty":-9.495324,"marketCap":1937574815},{"date":"2020-12-04","current":-23.368675,"twenty":-14.948251,"median":-11.696335,"eighty":-9.496356,"marketCap":2132321486},{"date":"2020-12-11","current":-41.953852,"twenty":-15.043385,"median":-11.704294,"eighty":-9.500036,"marketCap":3828163132},{"date":"2020-12-18","current":-43.64095,"twenty":-15.088641,"median":-11.723569,"eighty":-9.50088,"marketCap":3982105739},{"date":"2020-12-24","current":-56.595692,"twenty":-15.128873,"median":-11.7318,"eighty":-9.502766,"marketCap":5164187120},{"date":"2020-12-31","current":-47.502981,"twenty":-15.184063,"median":-11.739677,"eighty":-9.504402,"marketCap":4334504477},{"date":"2021-01-08","current":-61.372415,"twenty":-15.218689,"median":-11.753878,"eighty":-9.509969,"marketCap":5600048717},{"date":"2021-01-15","current":-51.588603,"twenty":-15.300215,"median":-11.76361,"eighty":-9.518237,"marketCap":4707305247},{"date":"2021-01-22","current":-47.610236,"twenty":-15.326415,"median":-11.786711,"eighty":-9.524342,"marketCap":4344291240},{"date":"2021-01-29","current":-44.417397,"twenty":-15.340268,"median":-11.796962,"eighty":-9.527421,"marketCap":4052954191},{"date":"2021-02-05","current":-46.379436,"twenty":-15.481226,"median":-11.816498,"eighty":-9.536792,"marketCap":4231984441},{"date":"2021-02-12","current":-41.948557,"twenty":-15.507188,"median":-11.832293,"eighty":-9.552935,"marketCap":3827679964},{"date":"2021-02-19","current":-40.898757,"twenty":-15.547358,"median":-11.842129,"eighty":-9.564473,"marketCap":3731888871},{"date":"2021-02-26","current":-25.427723,"twenty":-15.712133,"median":-11.872562,"eighty":-9.574724,"marketCap":2949005653},{"date":"2021-03-05","current":-24.134887,"twenty":-15.924312,"median":-11.879588,"eighty":-9.582836,"marketCap":2799067609},{"date":"2021-03-12","current":-26.830712,"twenty":-16.006827,"median":-11.880284,"eighty":-9.591308,"marketCap":3111718687},{"date":"2021-03-19","current":-26.088636,"twenty":-16.080571,"median":-11.892159,"eighty":-9.596008,"marketCap":3025655595},{"date":"2021-03-26","current":-23.468177,"twenty":-16.208001,"median":-11.899932,"eighty":-9.598852,"marketCap":2721745299},{"date":"2021-04-01","current":-24.830584,"twenty":-16.234579,"median":-11.908754,"eighty":-9.601082,"marketCap":2879751758},{"date":"2021-04-09","current":-22.876835,"twenty":-16.221473,"median":-11.901731,"eighty":-9.599967,"marketCap":2653163772},{"date":"2021-04-16","current":-20.099844,"twenty":-16.221473,"median":-11.901731,"eighty":-9.599967,"marketCap":2331099543},{"date":"2021-04-23","current":-21.467853,"twenty":-16.221473,"median":-11.901731,"eighty":-9.599967,"marketCap":2489755745},{"date":"2021-04-30","current":-21.526016,"twenty":-16.221473,"median":-11.901731,"eighty":-9.599967,"marketCap":2496501222},{"date":"2021-05-07","current":-17.112727,"twenty":-16.221473,"median":-11.901731,"eighty":-9.599967,"marketCap":2309875851},{"date":"2021-05-14","current":-16.66622,"twenty":-16.108417,"median":-11.901731,"eighty":-9.599967,"marketCap":2249606443},{"date":"2021-05-21","current":-16.661204,"twenty":-16.108417,"median":-11.901731,"eighty":-9.599967,"marketCap":2248929259},{"date":"2021-05-28","current":-17.032456,"twenty":-16.108417,"median":-11.901731,"eighty":-9.599967,"marketCap":2299040902},{"date":"2021-06-04","current":-16.891982,"twenty":-16.108417,"median":-11.901731,"eighty":-9.599967,"marketCap":2280079740},{"date":"2021-06-11","current":-18.773328,"twenty":-16.108417,"median":-11.901731,"eighty":-9.599967,"marketCap":2534023875},{"date":"2021-06-18","current":-18.000722,"twenty":-16.108417,"median":-11.901731,"eighty":-9.599967,"marketCap":2429737483},{"date":"2021-06-25","current":-21.010876,"twenty":-16.108417,"median":-11.901731,"eighty":-9.599967,"marketCap":2836048099},{"date":"2021-07-02","current":-27.542911,"twenty":-16.108417,"median":-11.901731,"eighty":-9.599967,"marketCap":3717742136},{"date":"2021-07-09","current":-24.367198,"twenty":-16.108417,"median":-11.901731,"eighty":-9.599967,"marketCap":3289084436},{"date":"2021-07-16","current":-21.26674,"twenty":-16.108417,"median":-11.901731,"eighty":-9.599967,"marketCap":2870584502},{"date":"2021-07-23","current":-20.489116,"twenty":-16.108417,"median":-11.901731,"eighty":-9.599967,"marketCap":2765620926},{"date":"2021-07-30","current":-21.000843,"twenty":-16.108417,"median":-11.901731,"eighty":-9.599967,"marketCap":2834693730},{"date":"2021-08-06","current":-22.7322,"twenty":-16.108417,"median":-11.901731,"eighty":-9.599967,"marketCap":3788639445},{"date":"2021-08-13","current":-25.623308,"twenty":-16.221473,"median":-11.922254,"eighty":-9.599967,"marketCap":4270482958},{"date":"2021-08-20","current":-24.690956,"twenty":-16.346335,"median":-11.978271,"eighty":-9.599967,"marketCap":4115093536},{"date":"2021-08-27","current":-26.796926,"twenty":-16.485487,"median":-12.001107,"eighty":-9.599967,"marketCap":4466082800},{"date":"2021-09-03","current":-27.909204,"twenty":-16.611034,"median":-12.059701,"eighty":-9.607878,"marketCap":4651459653},{"date":"2021-09-10","current":-27.030013,"twenty":-16.655184,"median":-12.086342,"eighty":-9.630533,"marketCap":4504930155},{"date":"2021-09-17","current":-25.844128,"twenty":-16.682456,"median":-12.108751,"eighty":-9.672273,"marketCap":4307285716},{"date":"2021-09-24","current":-24.00805,"twenty":-16.76879,"median":-12.151959,"eighty":-9.694305,"marketCap":4001277601},{"date":"2021-10-01","current":-16.32024,"twenty":-16.883875,"median":-12.201789,"eighty":-9.737892,"marketCap":2719996407},{"date":"2021-10-08","current":-14.561857,"twenty":-16.883875,"median":-12.247685,"eighty":-9.754324,"marketCap":2426937410},{"date":"2021-10-15","current":-15.547369,"twenty":-16.883875,"median":-12.282342,"eighty":-9.788564,"marketCap":2591186755},{"date":"2021-10-22","current":-15.465584,"twenty":-16.883875,"median":-12.336334,"eighty":-9.815579,"marketCap":2577556104},{"date":"2021-10-29","current":-15.015765,"twenty":-16.883875,"median":-12.361476,"eighty":-9.858049,"marketCap":2502587523},{"date":"2021-11-05","current":-15.334728,"twenty":-16.883875,"median":-12.409549,"eighty":-9.886928,"marketCap":2555747062},{"date":"2021-11-12","current":-12.005068,"twenty":-16.883875,"median":-12.419323,"eighty":-9.925802,"marketCap":2563862383},{"date":"2021-11-19","current":-11.197339,"twenty":-16.883875,"median":-12.419323,"eighty":-9.95139,"marketCap":2391359769},{"date":"2021-11-26","current":-10.253405,"twenty":-16.883875,"median":-12.419323,"eighty":-9.991547,"marketCap":2189768479},{"date":"2021-12-03","current":-8.780488,"twenty":-16.883875,"median":-12.419323,"eighty":-9.993914,"marketCap":1875204888},{"date":"2021-12-10","current":-9.189104,"twenty":-16.883875,"median":-12.419323,"eighty":-10.000584,"marketCap":1962470916},{"date":"2021-12-17","current":-9.464682,"twenty":-16.883875,"median":-12.419323,"eighty":-10.000584,"marketCap":2021324749},{"date":"2021-12-23","current":-9.483687,"twenty":-16.883875,"median":-12.419323,"eighty":-9.993914,"marketCap":2025383634},{"date":"2021-12-31","current":-8.409883,"twenty":-16.883875,"median":-12.419323,"eighty":-9.993914,"marketCap":1796056630},{"date":"2022-01-07","current":-7.963256,"twenty":-16.881172,"median":-12.419282,"eighty":-9.986059,"marketCap":1700672831},{"date":"2022-01-14","current":-7.000317,"twenty":-16.881172,"median":-12.419282,"eighty":-9.93989,"marketCap":1495022656},{"date":"2022-01-21","current":-5.749129,"twenty":-16.881172,"median":-12.419282,"eighty":-9.937554,"marketCap":1227812724},{"date":"2022-01-28","current":-5.521064,"twenty":-16.881172,"median":-12.419282,"eighty":-9.926348,"marketCap":1179106104},{"date":"2022-02-04","current":-5.932848,"twenty":-16.881172,"median":-12.419282,"eighty":-9.919692,"marketCap":1267048613},{"date":"2022-02-11","current":-5.109281,"twenty":-16.881172,"median":-12.419282,"eighty":-9.887898,"marketCap":1091163594},{"date":"2022-02-18","current":-4.814698,"twenty":-16.881172,"median":-12.406307,"eighty":-9.858312,"marketCap":1028250876},{"date":"2022-02-25","current":-6.010629,"twenty":-16.881172,"median":-12.360056,"eighty":-9.804434,"marketCap":1157058009},{"date":"2022-03-04","current":-5.711875,"twenty":-16.881172,"median":-12.34213,"eighty":-9.769288,"marketCap":1099547434},{"date":"2022-03-11","current":-5.356217,"twenty":-16.881172,"median":-12.310788,"eighty":-9.746267,"marketCap":1031082463},{"date":"2022-03-18","current":-6.52989,"twenty":-16.881172,"median":-12.263805,"eighty":-9.691215,"marketCap":1257016867},{"date":"2022-03-25","current":-6.672153,"twenty":-16.881172,"median":-12.248011,"eighty":-9.668261,"marketCap":1284402855},{"date":"2022-04-01","current":-7.191415,"twenty":-16.881172,"median":-12.204066,"eighty":-9.631246,"marketCap":1384361713},{"date":"2022-04-08","current":-6.526333,"twenty":-16.881172,"median":-12.167156,"eighty":-9.596417,"marketCap":1256332217},{"date":"2022-04-14","current":-5.928827,"twenty":-16.881172,"median":-12.134779,"eighty":-9.570656,"marketCap":1141311066},{"date":"2022-04-22","current":-5.189057,"twenty":-16.881172,"median":-12.123276,"eighty":-9.504402,"marketCap":998903926},{"date":"2022-04-29","current":-4.717233,"twenty":-16.881172,"median":-12.123276,"eighty":-9.489816,"marketCap":908076733},{"date":"2022-05-06","current":-5.030602,"twenty":-16.881172,"median":-12.104423,"eighty":-9.45473,"marketCap":937145884},{"date":"2022-05-13","current":-4.371395,"twenty":-16.881172,"median":-12.104423,"eighty":-9.401069,"marketCap":814342726},{"date":"2022-05-20","current":-4.058363,"twenty":-16.881172,"median":-12.104423,"eighty":-9.387507,"marketCap":756028378},{"date":"2022-05-27","current":-4.301423,"twenty":-16.881172,"median":-12.104423,"eighty":-9.387507,"marketCap":801307754},{"date":"2022-06-03","current":-4.386125,"twenty":-16.881172,"median":-12.104423,"eighty":-9.387507,"marketCap":817086931},{"date":"2022-06-10","current":-4.098873,"twenty":-16.881172,"median":-12.104423,"eighty":-9.387507,"marketCap":763574941},{"date":"2022-06-17","current":-4.157797,"twenty":-16.881172,"median":-12.104423,"eighty":-9.387507,"marketCap":774551759},{"date":"2022-06-24","current":-4.960631,"twenty":-16.883875,"median":-12.108751,"eighty":-9.398084,"marketCap":924110912},{"date":"2022-07-01","current":-4.636551,"twenty":-16.883875,"median":-12.108751,"eighty":-9.398084,"marketCap":863738410},{"date":"2022-07-08","current":-5.524088,"twenty":-16.883875,"median":-12.108751,"eighty":-9.398084,"marketCap":1029076740},{"date":"2022-07-15","current":-5.520405,"twenty":-16.883875,"median":-12.108751,"eighty":-9.398084,"marketCap":1028390688},{"date":"2022-07-22","current":-5.873946,"twenty":-16.883875,"median":-12.108751,"eighty":-9.398084,"marketCap":1094251600},{"date":"2022-07-29","current":-5.859215,"twenty":-16.883875,"median":-12.108751,"eighty":-9.398084,"marketCap":1091507395},{"date":"2022-08-05","current":-7.233762,"twenty":-16.883875,"median":-12.108751,"eighty":-9.398084,"marketCap":1334527835},{"date":"2022-08-12","current":-6.991643,"twenty":-16.883875,"median":-12.094472,"eighty":-9.371064,"marketCap":1289860322},{"date":"2022-08-19","current":-5.483058,"twenty":-16.883875,"median":-12.059701,"eighty":-9.331056,"marketCap":1011547360},{"date":"2022-08-26","current":-5.524032,"twenty":-16.883875,"median":-12.001901,"eighty":-9.255197,"marketCap":1019106477},{"date":"2022-09-02","current":-5.524032,"twenty":-16.883875,"median":-11.974337,"eighty":-9.207385,"marketCap":1019106477},{"date":"2022-09-09","current":-5.896522,"twenty":-16.883875,"median":-11.895461,"eighty":-9.12964,"marketCap":1087825727},{"date":"2022-09-16","current":-5.376898,"twenty":-16.883875,"median":-11.879641,"eighty":-9.047417,"marketCap":991962373},{"date":"2022-09-23","current":-4.738077,"twenty":-16.883875,"median":-11.842129,"eighty":-8.946781,"marketCap":874108860},{"date":"2022-09-30","current":-4.559282,"twenty":-16.815935,"median":-11.816969,"eighty":-8.869813,"marketCap":841123620},{"date":"2022-10-07","current":-4.469884,"twenty":-16.697322,"median":-11.765949,"eighty":-8.806514,"marketCap":824631000},{"date":"2022-10-14","current":-4.23894,"twenty":-16.629859,"median":-11.741466,"eighty":-8.655633,"marketCap":782025065},{"date":"2022-10-21","current":-4.373036,"twenty":-16.524061,"median":-11.720355,"eighty":-8.555441,"marketCap":806763995},{"date":"2022-10-28","current":-4.745527,"twenty":-16.485487,"median":-11.656636,"eighty":-8.444856,"marketCap":875483245},{"date":"2022-11-04","current":-3.84568,"twenty":-16.343299,"median":-11.6429,"eighty":-8.358041,"marketCap":773481697},{"date":"2022-11-11","current":-4.417516,"twenty":-16.281868,"median":-11.591255,"eighty":-8.222036,"marketCap":888495062},{"date":"2022-11-18","current":-3.661757,"twenty":-16.281868,"median":-11.581051,"eighty":-8.137092,"marketCap":736489094},{"date":"2022-11-25","current":-3.354102,"twenty":-16.24506,"median":-11.548293,"eighty":-8.109799,"marketCap":674610558},{"date":"2022-12-02","current":-3.427672,"twenty":-16.141207,"median":-11.523303,"eighty":-8.019889,"marketCap":689407599},{"date":"2022-12-09","current":-3.160146,"twenty":-16.0693,"median":-11.488755,"eighty":-7.945223,"marketCap":635600177},{"date":"2022-12-16","current":-3.43436,"twenty":-16.0693,"median":-11.453508,"eighty":-7.848032,"marketCap":690752785},{"date":"2022-12-23","current":-2.956158,"twenty":-16.003727,"median":-11.420306,"eighty":-7.775758,"marketCap":594572017},{"date":"2022-12-30","current":-2.96619,"twenty":-15.961368,"median":-11.391955,"eighty":-7.705112,"marketCap":596589795},{"date":"2023-01-06","current":-3.009663,"twenty":-15.961368,"median":-11.377414,"eighty":-7.483539,"marketCap":605333502},{"date":"2023-01-13","current":-2.819051,"twenty":-15.961368,"median":-11.372558,"eighty":-7.22218,"marketCap":566995713},{"date":"2023-01-20","current":-2.691976,"twenty":-15.961368,"median":-11.372558,"eighty":-7.13021,"marketCap":541437187},{"date":"2023-01-27","current":-3.200275,"twenty":-15.961368,"median":-11.349342,"eighty":-6.954088,"marketCap":643671290},{"date":"2023-02-03","current":-3.765423,"twenty":-15.961368,"median":-11.292524,"eighty":-6.801475,"marketCap":757339470},{"date":"2023-02-10","current":-3.263812,"twenty":-15.961368,"median":-11.246848,"eighty":-6.690945,"marketCap":656450553},{"date":"2023-02-17","current":-3.394231,"twenty":-15.961368,"median":-11.215729,"eighty":-6.528467,"marketCap":682681671},{"date":"2023-02-24","current":-2.773138,"twenty":-15.961368,"median":-11.197339,"eighty":-6.393489,"marketCap":611288329},{"date":"2023-03-03","current":-2.742529,"twenty":-15.961368,"median":-11.165485,"eighty":-6.262577,"marketCap":604541217},{"date":"2023-03-10","current":-2.396652,"twenty":-15.919278,"median":-11.124847,"eighty":-6.172097,"marketCap":528298853},{"date":"2023-03-17","current":-2.561939,"twenty":-15.801722,"median":-11.076247,"eighty":-6.075078,"marketCap":564733257},{"date":"2023-03-24","current":-2.283401,"twenty":-15.801722,"median":-11.041522,"eighty":-6.033023,"marketCap":503334540},{"date":"2023-03-31","current":-2.219122,"twenty":-15.795179,"median":-11.019296,"eighty":-5.984885,"marketCap":489165605},{"date":"2023-04-06","current":-2.096688,"twenty":-15.795179,"median":-10.985447,"eighty":-5.950266,"marketCap":462177158},{"date":"2023-04-14","current":-2.341557,"twenty":-15.801722,"median":-10.965378,"eighty":-5.910349,"marketCap":516154052},{"date":"2023-04-21","current":-2.342369,"twenty":-15.801722,"median":-10.883119,"eighty":-5.856993,"marketCap":516333085},{"date":"2023-04-28","current":-2.45566,"twenty":-15.801722,"median":-10.818743,"eighty":-5.771923,"marketCap":541306058},{"date":"2023-05-05","current":-2.669994,"twenty":-15.801722,"median":-10.785351,"eighty":-5.70397,"marketCap":588552223},{"date":"2023-05-12","current":-2.946969,"twenty":-15.801722,"median":-10.761252,"eighty":-5.641157,"marketCap":645247620},{"date":"2023-05-19","current":-2.882812,"twenty":-15.801722,"median":-10.738911,"eighty":-5.572384,"marketCap":631200335},{"date":"2023-05-26","current":-2.778761,"twenty":-15.801722,"median":-10.705427,"eighty":-5.524032,"marketCap":608418157},{"date":"2023-06-02","current":-2.922596,"twenty":-15.801722,"median":-10.662559,"eighty":-5.519621,"marketCap":639911167},{"date":"2023-06-09","current":-2.937898,"twenty":-15.801722,"median":-10.60058,"eighty":-5.476274,"marketCap":643261488},{"date":"2023-06-16","current":-3.301778,"twenty":-15.801722,"median":-10.557173,"eighty":-5.409305,"marketCap":722934132},{"date":"2023-06-23","current":-2.853476,"twenty":-15.774438,"median":-10.502997,"eighty":-5.341279,"marketCap":624777127},{"date":"2023-06-30","current":-2.899729,"twenty":-15.781537,"median":-10.494163,"eighty":-5.284711,"marketCap":634904437},{"date":"2023-07-07","current":-2.963772,"twenty":-15.781537,"median":-10.444409,"eighty":-5.182883,"marketCap":648926867},{"date":"2023-07-14","current":-3.184365,"twenty":-15.781537,"median":-10.396723,"eighty":-5.058555,"marketCap":697226345},{"date":"2023-07-21","current":-3.120322,"twenty":-15.781537,"median":-10.360943,"eighty":-4.977281,"marketCap":683203916},{"date":"2023-07-28","current":-3.087699,"twenty":-15.781537,"median":-10.34873,"eighty":-4.944989,"marketCap":676060853},{"date":"2023-08-04","current":-3.598844,"twenty":-15.788636,"median":-10.321347,"eighty":-4.802273,"marketCap":740606133},{"date":"2023-08-11","current":-3.347582,"twenty":-15.788636,"median":-10.317073,"eighty":-4.739667,"marketCap":688898938},{"date":"2023-08-18","current":-3.278002,"twenty":-15.788636,"median":-10.299937,"eighty":-4.667304,"marketCap":674580022},{"date":"2023-08-25","current":-3.405566,"twenty":-15.788636,"median":-10.256154,"eighty":-4.584993,"marketCap":700831368},{"date":"2023-09-01","current":-3.444221,"twenty":-15.788636,"median":-10.232067,"eighty":-4.529482,"marketCap":708786321},{"date":"2023-09-08","current":-3.444221,"twenty":-15.788636,"median":-10.208625,"eighty":-4.469884,"marketCap":708786321},{"date":"2023-09-15","current":-3.247077,"twenty":-15.788636,"median":-10.188645,"eighty":-4.440085,"marketCap":668216060},{"date":"2023-09-22","current":-3.092455,"twenty":-15.788636,"median":-10.14847,"eighty":-4.371395,"marketCap":636396248},{"date":"2023-09-29","current":-2.674973,"twenty":-15.788636,"median":-10.128125,"eighty":-4.323882,"marketCap":550482754},{"date":"2023-10-06","current":-2.771613,"twenty":-15.788636,"median":-10.094935,"eighty":-4.268278,"marketCap":570370137},{"date":"2023-10-13","current":-2.644049,"twenty":-15.788636,"median":-10.094935,"eighty":-4.194624,"marketCap":544118792},{"date":"2023-10-20","current":-2.48556,"twenty":-15.788636,"median":-10.057326,"eighty":-4.098873,"marketCap":511503484},{"date":"2023-10-27","current":-2.516485,"twenty":-15.808264,"median":-10.075641,"eighty":-4.071621,"marketCap":517867446},{"date":"2023-11-03","current":-2.717495,"twenty":-15.808264,"median":-10.075641,"eighty":-3.988391,"marketCap":559233202},{"date":"2023-11-10","current":-3.294864,"twenty":-15.808264,"median":-10.05679,"eighty":-3.864591,"marketCap":642771924},{"date":"2023-11-17","current":-3.675846,"twenty":-15.808264,"median":-10.031276,"eighty":-3.751541,"marketCap":717094980},{"date":"2023-11-24","current":-4.429436,"twenty":-15.808264,"median":-9.988106,"eighty":-3.751541,"marketCap":864107619},{"date":"2023-12-01","current":-4.408503,"twenty":-15.808264,"median":-9.90049,"eighty":-3.751541,"marketCap":860023934},{"date":"2023-12-08","current":-4.563407,"twenty":-15.808264,"median":-9.872667,"eighty":-3.751541,"marketCap":890243199},{"date":"2023-12-15","current":-4.538288,"twenty":-15.808264,"median":-9.791876,"eighty":-3.751541,"marketCap":885342777},{"date":"2023-12-21","current":-4.274531,"twenty":-15.808264,"median":-9.778557,"eighty":-3.751541,"marketCap":833888354},{"date":"2023-12-29","current":-4.333144,"twenty":-15.82881,"median":-9.787807,"eighty":-3.75003,"marketCap":845322670},{"date":"2024-01-05","current":-3.994028,"twenty":-15.83627,"median":-9.791589,"eighty":-3.748855,"marketCap":779166983},{"date":"2024-01-12","current":-3.834937,"twenty":-15.83627,"median":-9.751631,"eighty":-3.748855,"marketCap":748130982},{"date":"2024-01-19","current":-3.420462,"twenty":-15.843731,"median":-9.716106,"eighty":-3.708021,"marketCap":667274030},{"date":"2024-01-26","current":-3.257184,"twenty":-15.83627,"median":-9.701628,"eighty":-3.682725,"marketCap":635421292},{"date":"2024-02-02","current":-3.022734,"twenty":-15.83627,"median":-9.701628,"eighty":-3.636592,"marketCap":589684027},{"date":"2024-02-09","current":-3.001801,"twenty":-15.83627,"median":-9.701628,"eighty":-3.54008,"marketCap":585600342},{"date":"2024-02-16","current":-3.479075,"twenty":-15.83627,"median":-9.701628,"eighty":-3.51008,"marketCap":678708347},{"date":"2024-02-23","current":-3.319984,"twenty":-15.83627,"median":-9.701628,"eighty":-3.496528,"marketCap":647672345},{"date":"2024-03-01","current":-5.233355,"twenty":-15.82881,"median":-9.701122,"eighty":-3.490798,"marketCap":801849432},{"date":"2024-03-08","current":-4.603896,"twenty":-15.82881,"median":-9.664794,"eighty":-3.490798,"marketCap":705404321},{"date":"2024-03-15","current":-4.239746,"twenty":-15.82881,"median":-9.62927,"eighty":-3.490798,"marketCap":649609629},{"date":"2024-03-22","current":-4.073277,"twenty":-15.82881,"median":-9.587859,"eighty":-3.490798,"marketCap":624103484},{"date":"2024-03-28","current":-3.870394,"twenty":-15.82881,"median":-9.543416,"eighty":-3.490798,"marketCap":593017870},{"date":"2024-04-05","current":-3.636313,"twenty":-15.83627,"median":-9.491348,"eighty":-3.48996,"marketCap":557152318},{"date":"2024-04-12","current":-3.513501,"twenty":-15.83627,"median":-9.456994,"eighty":-3.48996,"marketCap":538335133},{"date":"2024-04-19","current":-2.97876,"twenty":-15.83627,"median":-9.404054,"eighty":-3.479075,"marketCap":456402640},{"date":"2024-04-26","current":-2.801645,"twenty":-15.82881,"median":-9.350281,"eighty":-3.464456,"marketCap":429265186},{"date":"2024-05-03","current":-3.01633,"twenty":-15.82881,"median":-9.289926,"eighty":-3.439826,"marketCap":462159070},{"date":"2024-05-10","current":-2.752272,"twenty":-15.82881,"median":-9.220307,"eighty":-3.416389,"marketCap":457243135},{"date":"2024-05-17","current":-2.915626,"twenty":-15.82881,"median":-9.085127,"eighty":-3.397114,"marketCap":484381666},{"date":"2024-05-24","current":-2.885925,"twenty":-15.82881,"median":-8.950166,"eighty":-3.385465,"marketCap":479447388},{"date":"2024-05-31","current":-2.559217,"twenty":-15.82881,"median":-8.826417,"eighty":-3.36237,"marketCap":425170325},{"date":"2024-06-07","current":-2.68792,"twenty":-15.82881,"median":-8.766234,"eighty":-3.350675,"marketCap":446552198},{"date":"2024-06-14","current":-2.717621,"twenty":-15.83627,"median":-8.573632,"eighty":-3.342194,"marketCap":451486477},{"date":"2024-06-21","current":-2.494865,"twenty":-15.843731,"median":-8.388241,"eighty":-3.330694,"marketCap":414479388},{"date":"2024-06-28","current":-2.346361,"twenty":-15.869657,"median":-8.220457,"eighty":-3.320526,"marketCap":389807996},{"date":"2024-07-05","current":-2.30676,"twenty":-15.869657,"median":-8.11085,"eighty":-3.30996,"marketCap":383228958},{"date":"2024-07-12","current":-2.70772,"twenty":-15.869657,"median":-7.940352,"eighty":-3.286923,"marketCap":449841717},{"date":"2024-07-15","current":-2.742371,"twenty":-15.869657,"median":-7.855103,"eighty":-3.284187,"marketCap":455598375},{"date":"2024-08-02","current":-2.544366,"twenty":-15.953842,"median":-7.347229,"eighty":-3.264998,"marketCap":422703186},{"date":"2024-08-09","current":-1.787597,"twenty":-15.953842,"median":-7.162303,"eighty":-3.24663,"marketCap":345810680},{"date":"2024-08-16","current":-1.700449,"twenty":-15.953842,"median":-6.976743,"eighty":-3.211636,"marketCap":328951896},{"date":"2024-08-23","current":-1.611176,"twenty":-15.953842,"median":-6.843993,"eighty":-3.185374,"marketCap":311681921},{"date":"2024-08-30","current":-1.577167,"twenty":-15.953842,"median":-6.719726,"eighty":-3.151591,"marketCap":305102883},{"date":"2024-09-06","current":-1.483642,"twenty":-15.953842,"median":-6.622361,"eighty":-3.138444,"marketCap":287010529},{"date":"2024-09-13","current":-1.594171,"twenty":-15.953842,"median":-6.435303,"eighty":-3.121599,"marketCap":308392402},{"date":"2024-09-20","current":-1.662189,"twenty":-15.953842,"median":-6.275364,"eighty":-3.093228,"marketCap":321550478},{"date":"2024-09-27","current":-1.483642,"twenty":-15.953842,"median":-6.196862,"eighty":-3.077139,"marketCap":287010529},{"date":"2024-10-04","current":-1.360359,"twenty":-15.953842,"median":-6.083958,"eighty":-3.063375,"marketCap":263161516},{"date":"2024-10-11","current":-1.258332,"twenty":-15.953842,"median":-6.037006,"eighty":-3.043822,"marketCap":243424403},{"date":"2024-10-18","current":-1.407122,"twenty":-15.953842,"median":-5.99337,"eighty":-3.033351,"marketCap":272207693},{"date":"2024-10-25","current":-1.351857,"twenty":-15.953842,"median":-5.947885,"eighty":-3.01538,"marketCap":261516757},{"date":"2024-10-31","current":-1.283839,"twenty":-15.953842,"median":-5.921714,"eighty":-3.006409,"marketCap":248358681},{"date":"2024-11-08","current":-1.242698,"twenty":-15.960385,"median":-5.859994,"eighty":-2.989878,"marketCap":261677473},{"date":"2024-11-15","current":-1.085891,"twenty":-15.960385,"median":-5.774469,"eighty":-2.97876,"marketCap":228658234},{"date":"2024-11-22","current":-0.929084,"twenty":-15.960385,"median":-5.743801,"eighty":-2.969534,"marketCap":195638994},{"date":"2024-11-29","current":-0.878121,"twenty":-15.960385,"median":-5.66564,"eighty":-2.963772,"marketCap":184907741},{"date":"2024-12-06","current":-0.748755,"twenty":-15.960385,"median":-5.612291,"eighty":-2.950139,"marketCap":157666869},{"date":"2024-12-13","current":-0.740915,"twenty":-15.960385,"median":-5.524232,"eighty":-2.940958,"marketCap":156015907},{"date":"2024-12-20","current":-0.525305,"twenty":-15.960385,"median":-5.520405,"eighty":-2.931751,"marketCap":110614452},{"date":"2024-12-27","current":-0.482183,"twenty":-15.960385,"median":-5.497957,"eighty":-2.922596,"marketCap":101534161},{"date":"2025-01-03","current":-0.513544,"twenty":-15.960385,"median":-5.475608,"eighty":-2.888933,"marketCap":108138009},{"date":"2025-01-10","current":-0.525305,"twenty":-15.967171,"median":-5.403904,"eighty":-2.8736,"marketCap":110614452},{"date":"2025-01-17","current":-0.486103,"twenty":-15.967171,"median":-5.328966,"eighty":-2.853476,"marketCap":102359642},{"date":"2025-01-24","current":-0.552746,"twenty":-15.967171,"median":-5.277511,"eighty":-2.843752,"marketCap":116392819},{"date":"2025-01-31","current":-0.537065,"twenty":-15.967171,"median":-5.170932,"eighty":-2.811651,"marketCap":113090895},{"date":"2025-02-07","current":-0.509624,"twenty":-15.967171,"median":-5.068175,"eighty":-2.800571,"marketCap":107312528},{"date":"2025-02-14","current":-0.482183,"twenty":-15.967171,"median":-4.982565,"eighty":-2.784359,"marketCap":101534161},{"date":"2025-02-21","current":-0.807558,"twenty":-15.967171,"median":-4.953652,"eighty":-2.77501,"marketCap":170049083},{"date":"2025-02-28","current":-0.717394,"twenty":-15.967171,"median":-4.808485,"eighty":-2.767016,"marketCap":151063021},{"date":"2025-03-07","current":-0.622953,"twenty":-15.973957,"median":-4.749252,"eighty":-2.748663,"marketCap":147697785},{"date":"2025-03-14","current":-0.479464,"twenty":-15.973957,"median":-4.723545,"eighty":-2.739402,"marketCap":113677509},{"date":"2025-03-21","current":-0.479464,"twenty":-15.973957,"median":-4.651326,"eighty":-2.725226,"marketCap":113677509},{"date":"2025-03-28","current":-0.454966,"twenty":-15.973957,"median":-4.603896,"eighty":-2.708946,"marketCap":107869169},{"date":"2025-04-04","current":-0.39197,"twenty":-15.973957,"median":-4.575967,"eighty":-2.676801,"marketCap":92933438},{"date":"2025-04-11","current":-0.388471,"twenty":-15.967171,"median":-4.543197,"eighty":-2.662603,"marketCap":92103675},{"date":"2025-04-17","current":-0.444466,"twenty":-15.967171,"median":-4.531458,"eighty":-2.633468,"marketCap":105379880},{"date":"2025-04-24","current":-0.545959,"twenty":-15.973957,"median":-4.496422,"eighty":-2.618581,"marketCap":129443003}],"updateTime":1745577574152}}}